Large Language Models Assist in Tumor MDT
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Study ID
- NCT07504367
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 33 Years
- Healthy Volunteers
- Accepted
Interventions
- LLM assists in MDT report writing — OTHERThis study was a prospective RCT, and the intervention content was an auxiliary tool for writing MDT reports. The intervention group used LLM to assist in the writing of MDT reports. The prescribed MDT medical records (excluding diagnosis and treatment opinions) were input into the LLM, and the output content could be used as a reference for the MDT report. Finally, the MDT diagnosis and treatment opinions were written under the personal judgment of the doctors. The control group used traditional information retrieval methods (such as Google, literature, and textbooks) to write MDT diagnosis and treatment opinions.
Study Details
Multidisciplinary teams (MDTs) represent the gold standard for personalized tumor treatment, but they are limited by medical resources and accessibility Limitation. Although large language models (LLMs) have shown promise in medical reasoning, their multidisciplinary practicality in pan-cancer MDTs has not been fully explored. In the early stage of this project, LLMs with high clinical application efficacy were identified through benchmark tests, and an open-label randomized controlled study (RCT) was conducted based on these LLMs. The research aims to explore whether AI-assisted assistance can enhance the accuracy and writing efficiency of MDT diagnosis and treatment reports. This study intends to prospectively collect the diagnosis and treatment information of 20 patients and MDT diagnosis and treatment information. It is planned to recruit 40 junior doctors. Doctors in the intervention group will use LLM to assist in the writing of MDT reports, while doctors in the control group will use traditional information retrieval methods for the writing of MDT reports. Three clinical experts ultimately used a standardized Likert scale to conduct comprehensive and multidisciplinary scoring of the MDT reports of the intervention group and the control group. This study quantitatively compared the diagnosis and treatment quality and efficiency of the MDT AI-assisted model and the traditional model to verify the application potential of large language models in assisting tumor diagnosis and treatment.
Key Dates
- First listed
- Mar 31, 2026
- Start date
- Jan 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: AI-MDTThis study was a prospective RCT, and the intervention content was an auxiliary tool for writing MDT reports. The intervention group used LLM to assist in the writing of MDT reports. The prescribed MDT medical records (excluding diagnosis and treatment opinions) were input into the LLM, and the output content could be used as a reference for the MDT report. Finally, the MDT diagnosis and treatment opinions were written under the personal judgment of the doctors.
- No Intervention: Trad-MDTThe control group used traditional information retrieval methods (such as Google, literature, and textbooks) to write MDT diagnosis and treatment opinions.
Primary Outcome Measure
The overall score of the MDT report [ Time Frame: Up to 4 weeks, complete the writing of medical opinions for all cases (n=20). ]
Central Contacts
- Yunfang Yu, PhD+8613660238987
- Herui Yao, PhD+8613500018020
Find similar trials
Related Studies
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- Detection of Genetic Markers of Lung CancerRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania